Keywords

• Somatostatin
• Somatostatin Acetate
• 51110-01-1

Quick Details

• ProName: Somatostatin
• CasNo: 51110-01-1
• Molecular Formula: C76h104n18o19s2
• Appearance: white powder
• Application: hormone-inhibiting hormone
• DeliveryTime: 5 days
• PackAge: Vial or customized
• Port: Shanghai, Beijing, Shenzhen etc.
• ProductionCapacity: 100 Kilogram/Month
• Purity: 99%
• Storage: 2-8℃ sealed and away from light
• Transportation: Ocean and air shipping
• LimitNum: 10 Milligram
• Related Substances: Effective ingredients >99%
• Residue on Ignition: 0.1
• Heavy Metal: 0
• Valid Period: 3 years

Superiority

GMP Manafacturer

High Purity

Competitive Price

Short Delivery Time

Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.

For patients suffering from acromegaly, a condition characterized by excessive growth hormone production leading to abnormal skeletal and soft - tissue growth, our somatostatin effectively curtails the over - secretion of growth hormone, thereby alleviating symptoms and improving the quality of life. In cases of gastro - intestinal fistulas, where the normal flow of digestive fluids is disrupted, it regulates the secretion of digestive hormones, promoting the healing process and reducing the risk of complications. Additionally, in the management of severe acute pancreatitis, our somatostatin rapidly suppresses the release of pancreatic enzymes, mitigating the severity of the condition and enhancing patient prognosis.

Details

Somatostatin Acetate:
CAS No.: 51110-01-1

Sequence: Ala-Gly-c[Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys]

Somatostatin is hormone-inhibiting hormone, it can helps the body to manage the endocrine system by impacting cell proliferation and neurotransmission by interacting with somatostatin receptors (G protein-coupled) to inhibit the release of secondary hormones throughout the body.

Company Profile 

Founded in 2011, Harbin Jixianglong Biotech Co., Ltd. is a is a professional high-tech company specializing in R&D and production of polypeptide pharmaceuticals. Our advanced industry chain occupied in R&D, approbation and industrialization of peptides API and preparation.
Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.
Jixianglong has 10 APIs production approvals, 16 invention patents achieved, including 5 compound patents.